ICAM1 and cystic fibrosis: The pretreatment of CF with IFN-β, prior to the stimulation with LPS, triggers a decrease in IL-8 levels, as well as a decrease in ICAM-1 and VCAM-1 expression levels, while such anti-inflammatory effects are blocked by JAK inhibition.